Cargando…

Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib

BACKGROUND: Our objective was to evaluate the effect of background biological disease-modifying anti-rheumatic drugs (bDMARDs) and/or corticosteroids (CS) on response to nonsteroidal anti-inflammatory drugs (NSAIDs) in rheumatoid arthritis (RA) patients. METHODS: The following efficacy endpoints wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kvien, Tore K, Greenwald, Maria, Peloso, Paul M, Wang, Hongwei, Mehta, Anish, Gammaitoni, Arnold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344787/ https://www.ncbi.nlm.nih.gov/pubmed/25886874 http://dx.doi.org/10.1186/s12891-015-0468-7

Ejemplares similares

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial
por: Bickham, Kara, et al.
Publicado: (2016)

Longitudinal Numbers-Needed-To-Treat (NNT) for Achieving Various Levels of Analgesic Response and Improvement with Etoricoxib, Naproxen, and Placebo in Ankylosing Spondylitis
por: Peloso, Paul M, et al.
Publicado: (2011)

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice
por: Moore, R A, et al.
Publicado: (2010)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
por: Arnao, Valentina, et al.
Publicado: (2017)

Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion
por: Kwiatkowska, Brygida, et al.
Publicado: (2017)

A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis
por: Balazcs, Eva, et al.
Publicado: (2016)

Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor
por: Hammer, Hilde Berner, et al.
Publicado: (2019)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study
por: Hammer, Hilde Berner, et al.
Publicado: (2017)

Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity
por: Loh, Wenyin, et al.
Publicado: (2015)

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
por: Tjandrawinata, Raymond R, et al.
Publicado: (2018)

Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial
por: Rawal, Narinder, et al.
Publicado: (2013)

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
por: Provan, Sella Aarrestad, et al.
Publicado: (2015)

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac
por: Walker, Chris
Publicado: (2018)

Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief
por: Renner, B, et al.
Publicado: (2012)

Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis
por: Feng, Xiaoting, et al.
Publicado: (2018)

Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
por: Walker, Chris
Publicado: (2019)

Dr. Cox on Acute Rheumatism
Publicado: (1825)

Evaluation of a single preoperative dose of etoricoxib for postoperative pain relief in therapeutic knee arthroscopy: A randomized trial
por: Lierz, Peter, et al.
Publicado: (2012)

Etoricoxib for arthritis and pain management
por: Brooks, Peter, et al.
Publicado: (2006)

The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)

The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases
por: Chou, CT, et al.
Publicado: (2007)

Periodontal Condition in Patients with Rheumatoid Arthritis: Effect of Anti-rheumatic Drugs
por: Kordtabar, Samira, et al.
Publicado: (2019)

Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients
por: de Smit, Menke J., et al.
Publicado: (2021)

Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
por: Baoqi, Yang, et al.
Publicado: (2022)

Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities
por: Sulaiman, Sulaiman, et al.
Publicado: (2022)

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
por: Collantes, Eduardo, et al.
Publicado: (2002)

Etoricoxib-induced pretibial erythema and edema
por: Kumar, Pramod
Publicado: (2015)

Exantema fijo medicamentoso por etoricoxib
por: Cantero Macedo, Ana Margarita, et al.
Publicado: (2019)

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
por: Russell, Mark D, et al.
Publicado: (2022)

Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study
por: Yeole, Amit B., et al.
Publicado: (2022)

Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
por: Marcu, Iulia Rahela, et al.
Publicado: (2020)

Phenacetin as an Anti-Rheumatic
Publicado: (1890)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
por: Kirschneck, Christian, et al.
Publicado: (2019)

Correction to: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Publicado: (2022)

Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2022)

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
por: Giachi, Andrea, et al.
Publicado: (2022)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
por: Das, Priyam, et al.
Publicado: (2023)

Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate
por: Pollmann, Sylvie, et al.
Publicado: (2011)

Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2021)

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
por: Russell, Mark D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8mpanlbornjlv55ks0f6lscbk